Ulta Beauty Reports Strong Q2 2026 Earnings and Raises Full-Year Guidance
Ulta Beauty, Inc.
Subscribe to track ULTA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Ulta Beauty ($ULTA) reported strong Q2 2026 financial results, with net sales up 8.9% to $3.04 billion and diluted EPS up 13.3% to $6.55. The company raised its full-year 2026 guidance for sales, comparable sales, and EPS, and increased its stock repurchase plan for the year.
Comprehensive Analysis
Ulta Beauty, Inc. filed an 8-K to announce its financial results for the second quarter of fiscal 2026, reporting strong performance and raising its outlook for the full year.
Q2 2026 Financial Highlights:
- Net Sales: Increased 8.9% to $3.04 billion, compared to $2.79 billion in the prior year.
- Comparable Sales: Grew by 3.8%.
- Operating Income: Increased 10.1% to $379.6 million.
- Diluted EPS: Rose 13.3% to $6.55, up from $5.78 in Q2 2025.
Updated Fiscal 2026 Guidance: Reflecting confidence in its performance, Ulta raised its full-year guidance:
- Net Sales Growth: 6.7% to 7.2% (previously 6% to 7%).
- Comparable Sales Growth: 3.2% to 3.7% (previously 2.5% to 3.5%).
- Operating Income Growth: 8.3% to 9.3% (previously 6.5% to 9%).
- Diluted EPS: $28.70 to $29.00 (previously $28.36 to $28.80).
Capital Allocation: The company also announced an increase in its stock repurchase plan for fiscal 2026, from $1.5 billion to $1.8 billion, signaling a strong commitment to returning capital to shareholders.
This combination of a strong earnings beat, a significant guidance raise across key metrics, and an enhanced share buyback program is a clear positive signal of the company's operational strength and management's optimistic outlook.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
